Alison Ciling
Papers
2
Total Citations
27
H-Index
2
About
Alison Ciling is a molecular biology researcher whose work has made meaningful contributions to infectious disease surveillance, particularly in the context of the COVID-19 pandemic. Her research focuses on developing scalable, efficient diagnostic methodologies for detecting SARS-CoV-2, with a notable emphasis on saliva-based testing approaches that improve accessibility and throughput for large-scale population screening. Ciling's most recognized contribution centers on the development and optimization of robotic RNA extraction workflows for SARS-CoV-2 surveillance using saliva samples. This work addressed a critical need during the pandemic: enabling high-volume, asymptomatic surveillance without the discomfort and logistical challenges associated with nasopharyngeal swabs. By integrating automation into RNA extraction pipelines and evaluating direct-to-RT-qPCR protocols, her research helped lay the groundwork for streamlined, cost-effective testing programs applicable across institutions, universities, and communities. These methodological advances have collectively garnered nearly 30 citations, reflecting their practical utility within the diagnostic and public health research community. Her efforts exemplify how applied laboratory innovation can directly support public health infrastructure, particularly during rapidly evolving health crises where testing scalability and accessibility are paramount.
Research Focus
Key Achievements
Top Papers
- 1Robotic RNA extraction for SARS-CoV-2 surveillance using saliva samples18 citations · 2021
- 2Robotic RNA extraction for SARS-CoV-2 surveillance using saliva samples9 citations · 2021